FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved a supplemental application for norepinephrine bitartrate from Baxter Healthcare Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Hypotension
• Septic Shock

Drugs mentioned

• Norepinephrine bitartrate (Norepinephrine bitartrate)

Snippet

SUPPL AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)